Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin-Reference-Cited by-同舟云学术

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Published:2023-08 Issue:17 Volume:186 Page:3686-3705.e32
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Ruf Benjamin^ORCID,Bruhns Matthias,Babaei Sepideh,Kedei Noemi,Ma Lichun,Revsine Mahler,Benmebarek Mohamed-Reda,Ma Chi,Heinrich Bernd,Subramanyam Varun,Qi Jonathan,Wabitsch Simon,Green Benjamin L.,Bauer Kylynda C.,Myojin Yuta,Greten Layla T.,McCallen Justin D.,Huang Patrick,Trehan Rajiv,Wang Xin,Nur Amran,Murphy Soika Dana Qiang,Pouzolles Marie,Evans Christine N.,Chari Raj,Kleiner David E.,Telford William,Dadkhah Kimia,Ruchinskas Allison,Stovroff Merrill K.,Kang Jiman,Oza Kesha,Ruchirawat Mathuros,Kroemer Alexander,Wang Xin Wei,Claassen Manfred,Korangy Firouzeh,Greten Tim F.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference60 articles.

1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2016

2. Immunotherapies for hepatocellular carcinoma;Llovet;Nat. Rev. Clin. Oncol.,2022

3. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma;Greten;J. Immunother. Cancer,2021

4. Advances in immunotherapy for hepatocellular carcinoma;Sangro;Nat. Rev. Gastroenterol. Hepatol.,2021

5. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1;Treiner;Nature,2003

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal Drug Delivery Systems: A Novel Therapy Targeting PD-1 in Septic-ALI;Stem Cell Reviews and Reports;2024-09-05

2. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

3. LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy;iMeta;2024-09-04

4. Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment;Frontiers in Immunology;2024-09-03

5. Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis;Journal of Controlled Release;2024-09